|
DCAF17 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.425000E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.241900E-03 |
| Normal-vs-Stage2 |
1.902200E-01 |
| Normal-vs-Stage3 |
5.013500E-02 |
| Normal-vs-Stage4 |
1.455230E-01 |
| Stage1-vs-Stage2 |
8.847200E-01 |
| Stage1-vs-Stage3 |
7.998600E-01 |
| Stage1-vs-Stage4 |
7.953600E-01 |
| Stage2-vs-Stage3 |
7.750400E-01 |
| Stage2-vs-Stage4 |
7.670800E-01 |
| Stage3-vs-Stage4 |
9.349000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.436100E-03 |
| Normal-vs-AfricanAmerican |
5.239600E-02 |
| Normal-vs-Asian |
6.622300E-02 |
| Caucasian-vs-AfricanAmerican |
8.122600E-01 |
| Caucasian-vs-Asian |
7.443600E-01 |
| AfricanAmerican-vs-Asian |
6.940400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.559200E-04 |
| Normal-vs-Female |
9.081200E-01 |
| Male-vs-Female |
3.602700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.819100E-03 |
| Normal-vs-Extreme_Weight |
1.92565999999061E-05 |
| Normal-vs-Obese |
1.123440E-01 |
| Normal-vs-Extreme_Obese |
3.006400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.256200E-01 |
| Normal_Weight-vs-Obese |
2.643200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.543000E-01 |
| Extreme_Weight-vs-Obese |
2.978200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.109600E-01 |
| Obese-vs-Extreme_Obese |
8.287600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.448400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.961700E-02 |
| Normal-vs-Age(61-80Yrs) |
1.704640E-03 |
| Normal-vs-Age(81-100Yrs) |
1.569650E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.710600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.188350E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.378300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.179000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.983500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.970600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.599950E-02 |
| Normal-VS-Type2 PRCC |
1.388180E-04 |
| Normal-VS-KIRP CIMP |
8.724000E-01 |
| Normal-VS-Unclassified PRCC |
9.752400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.425810E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.167000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.255400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.869500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.956600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
8.956600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.446600E-04 |
| Normal-vs-N1 |
6.579000E-01 |
| Normal-vs-N2 |
8.214200E-02 |
| N0-vs-N1 |
5.069700E-02 |
| N0-vs-N2 |
8.267000E-01 |
| N1-vs-N2 |
4.635600E-01 |
|
|
